MAPT and Alzheimer disease: For example, rapamycin, an mTOR inhibitor, has been shown in multiple AD mouse models to restore autophagy, reduce Aβ and tau accumulation, and improve cognitive function by inhibiting mTORC1 activity [184,185,186,187].